Boji Medical Technology Co Ltd
SZSE:300404
Intrinsic Value
Boji Medical Technology Co., Ltd. is a contract research organization(CRO) that offers outsourcing drugs research and development services, including new drugs evaluation and clinical trials, preclini... [ Read More ]
The intrinsic value of one
Boji Medical Technology Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 7.57 CNY,
Boji Medical Technology Co Ltd
is
hidden
.
Boji Medical Technology Co Ltd's market capitalization is 2.9B CNY.
Boji Medical Technology Co Ltd stock price is 7.57 CNY.
Boji Medical Technology Co Ltd stock price (7.57 CNY) is 8% less than its Intrinsic Value (8.25 CNY).
Boji Medical Technology Co Ltd stock (2.53 CNY) is 67% less than its price (7.57 CNY). Open DCF Valuation
Boji Medical Technology Co Ltd stock price (7.57 CNY) is 46% less than its Relative Value (13.97 CNY). Open Relative Valuation
Boji Medical Technology Co Ltd has upside potential of 58% compared to the average analyst price target.
Open Wall St Estimates
Boji Medical Technology Co Ltd has positive Net Income for the last twelve months.
Boji Medical Technology Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 7% to 3%.
Boji Medical Technology Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 7% to 3%.
Boji Medical Technology Co Ltd has positive Operating Income for the last twelve months.
Boji Medical Technology Co Ltd's ROE (Return on Equity) for the past 12 months is very low and is equal to 3%.
Boji Medical Technology Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 3%.
Boji Medical Technology Co Ltd's Revenue has grown by an exceptional 37% over the past 12 months.
Boji Medical Technology Co Ltd has a very low three-year average ROE (Return on Equity): 4%. The company is not efficient at transforming stockholders' equity into net income.
Boji Medical Technology Co Ltd has a very low three-year average ROIC (Return on Invested Capital): 4%. The company is not efficient at using invested capital to generate operating income.
Boji Medical Technology Co Ltd's Revenue is forecast to grow at a rate of 31% per year over the next 3 years.
Boji Medical Technology Co Ltd has positive Gross Profit for the last twelve months.
Boji Medical Technology Co Ltd's Revenue has been growing by an exceptional 28% per year for the last 3 years.
Boji Medical Technology Co Ltd's short-term assets (815m CNY) exceed its short-term liabilties (358m CNY).
Boji Medical Technology Co Ltd has negative Free Cash Flow for the last twelve months.
Boji Medical Technology Co Ltd's long-term assets (1B CNY) exceed its long-term liabilties (473m CNY).
Boji Medical Technology Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.12.
Boji Medical Technology Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (403m CNY) than debt (110m CNY).
Boji Medical Technology Co Ltd's Altman Z-Score is very high and is equal to 4.43.
Valuation Backtest
Boji Medical Technology Co Ltd
Run backtest to discover the historical profit from buying and selling
Boji Medical Technology Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
This note will be permanently deleted.
Boji Medical Technology Co Ltd
Balance Sheet Decomposition
Boji Medical Technology Co Ltd
| Current Assets | 815.2m |
| Cash & Short-Term Investments | 402.5m |
| Receivables | 186.7m |
| Other Current Assets | 225.9m |
| Non-Current Assets | 613.7m |
| Long-Term Investments | 159.3m |
| PP&E | 337.9m |
| Intangibles | 50m |
| Other Non-Current Assets | 66.6m |
| Current Liabilities | 357.5m |
| Accounts Payable | 101.4m |
| Accrued Liabilities | 31.2m |
| Short-Term Debt | 32.5m |
| Other Current Liabilities | 192.3m |
| Non-Current Liabilities | 115.6m |
| Long-Term Debt | 77.7m |
| Other Non-Current Liabilities | 37.8m |
Earnings Waterfall
Boji Medical Technology Co Ltd
|
Revenue
|
620m
CNY
|
|
Cost of Revenue
|
-423.2m
CNY
|
|
Gross Profit
|
196.8m
CNY
|
|
Operating Expenses
|
-179.6m
CNY
|
|
Operating Income
|
17.2m
CNY
|
|
Other Expenses
|
11.9m
CNY
|
|
Net Income
|
29.1m
CNY
|
Free Cash Flow Analysis
Boji Medical Technology Co Ltd
| CNY | |
| Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Boji Medical Technology Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Boji Medical Technology Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Boji Medical Technology Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Boji Medical Technology Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Boji Medical Technology Co Ltd
According to Wall Street analysts, the average 1-year price target for
Boji Medical Technology Co Ltd
is 11.97 CNY
with a low forecast of 11.86 CNY and a high forecast of 12.33 CNY.
Shareholder Return
Price
Boji Medical Technology Co Ltd
| Average Annual Return | -3.28% |
| Standard Deviation of Annual Returns | 26.21% |
| Max Drawdown | -62% |
| Market Capitalization | 2.9B CNY |
| Shares Outstanding | 382 205 238 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Boji Medical Technology Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Boji Medical Technology Co., Ltd. is a contract research organization(CRO) that offers outsourcing drugs research and development services, including new drugs evaluation and clinical trials, preclinical studies and researches, medical devices registration, data management, biostatistics and other consultation services. The company is headquartered in Guangzhou, Guangdong and currently employs 989 full-time employees. The company went IPO on 2015-04-24. The firm mainly provides one-stop CRO services for the development and production of new drugs and medical devices for domestic and foreign pharmaceutical companies and other research institutions. The firm's CRO services include pre-clinical research services, clinical research services, other consulting services, pharmaceutical Contract Development Manufacture Organization (CDMO) services, pre-clinical independent research and development services, and technology achievement transformation services. The firm mainly conducts its businesses in the domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one
Boji Medical Technology Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 7.57 CNY,
Boji Medical Technology Co Ltd
is
hidden
.
You don't have any saved screeners yet
